Research for right cardiac function evaluation and warning model of neonatal pulmonary arterial hypertension

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000032622

Enrollment

Unknown

Registered

2020-05-04

Start date

2020-05-01

Completion date

Unknown

Last updated

2020-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary arterial hypertension

Interventions

Gold Standard:Clinical outcome

Index test:echocardiographic

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: In October 2018 to May 2020 in our hospital intensive care unit (NICU) appear in hospital centricity blue (premature PaO2 < 6.67 kPa, full term PaO2 < 8 kPa) neonatal cardiopulmonary disease.

Exclusion criteria

Exclusion criteria: Congenital heart disease (not including arterial catheter not closed) and affect the well known, myocardial motion of neuromuscular diseases

Design outcomes

Primary

Measure	Time frame
Death Rate;SEN, SPE, ACC, AUC of ROC;heart function assessment;	—

Countries

China

Contacts

Public ContactMaojun Li

Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital

hanman2012@163.com+86 18981838016

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026